GlassScriptPhysician profile
Jason M Gold
NPI 1316960628
$5,816.16
in general payments reported to CMS, 2019-2025
26 companies · $421 in 2025
The $421 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,457 · 2020: $1,327 · 2021: $511 · 2022: $800 · 2023: $656 · 2024: $646 · 2025: $421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,723.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,722.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,233.10 | 2019-2025 | Variax, Vitoss, Citrefix |
| Treace Medical Concepts, INC. | $555.25 | 2022-2025 | |
| Smith+Nephew, INC. | $371.65 | 2019-2024 | Collagenase Santyl, Stravix, Grafix Pl |
| Musculoskeletal Transplant Foundation INC. | $189.68 | 2020 | |
| Acell, INC. | $172.00 | 2020 | |
| Acera Surgical, INC. | $170.43 | 2022 | |
| Zimmer Biomet Holdings, INC. | $137.39 | 2023 | Accufill |
| Kerecis Limited | $136.84 | 2019-2022 | |
| Voom Medical Devices, INC. | $134.66 | 2025 | Revcon Instrument Kit, Sterile |
| In2bones USA, LLC | $122.98 | 2022 | |
| Djo, LLC | $82.25 | 2019-2024 | Cmf |
| Embody, INC. | $65.06 | 2022 | |
| Paratek Pharmaceuticals, INC. | $55.34 | 2020-2024 | Nuzyra |
| Biotissue Holdings INC. | $42.05 | 2023 | |
| Bioventus LLC | $38.89 | 2023-2024 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nabriva Therapeutics, Plc | $37.79 | 2022 | |
| Horizon Therapeutics Plc | $37.50 | 2019-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $36.01 | 2022-2023 | Jublia |
| Melinta Therapeutics, LLC | $34.78 | 2019 | |
| Tactile Systems Technology INC | $33.89 | 2021 | |
| Medtronic, INC. | $28.61 | 2024 | Closurefast |
| Medshape, INC. | $26.32 | 2022 | |
| Solventum Corporation | $25.47 | 2024 | Activ.A.C. |
| Heron Therapeutics, INC. | $22.75 | 2021 | |
| Amgen INC. | $19.66 | 2025 | Krystexxa |
| Fidia Pharma USA INC. | $5.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Gold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.